scholarly journals An educational series to encourage discussion within Diabetes Care Teams Clinical Problems in Diabetes Care - 7. Tony: worries about lifestyle and long-term diabetes control

2000 ◽  
Vol 17 (8) ◽  
pp. 269-277

RSC Advances ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 4740-4750
Author(s):  
Nada S. Abdelwahab ◽  
Amani Morsi ◽  
Yasmine M. Ahmed ◽  
Hossam M. Hassan ◽  
Asmaa M. AboulMagd

The combination of fenugreek extract and metformin can be considered as an auspicious treatment for satisfactory diabetes control and minimizing the expected long-term complications of metformin.



Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 856-P
Author(s):  
RUBÉN SILVA-TINOCO ◽  
VIRIDIANA DELATORRE-SALDAÑA ◽  
TERESA CUATECONTZI-XOCHITIOTZI ◽  
ARNULFO GONZALEZ-CANTU ◽  
CARMEN CASTILLO-GALINDO ◽  
...  


Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 853-P
Author(s):  
JOTHYDEV KESAVADEV ◽  
ARUN SHANKAR ◽  
GOPIKA KRISHNAN ◽  
ASHWIN DAVID ◽  
GEETHU SANAL ◽  
...  




Author(s):  
Dinesh Nagi ◽  
Emma Wilmot ◽  
Karissa Owen ◽  
Dipesh Patel ◽  
Lesley Mills ◽  
...  

At the time of submission of this manuscript, the COVID-19 pandemic had cost nearly 60,000 lives in the UK. This number currently stands at over 120,000 deaths. A high proportion (one third) of these lived with diabetes. The huge acute and emergency medicine effort to support people with COVID-19 has had a major knock-on impact on the delivery of routine clinical care, especially for long-term conditions like diabetes.Challenges to the delivery of diabetes services during this period include a reduction in medical and nursing staff, limitations placed by social distancing on physical clinical space, and balancing virtual vs face-to-face care. There is a need to re-group and re-organise how we deliver routine out-patient adult diabetes services during the ongoing COVID-19 pandemic. We offer some suggestions for how patients can be stratified into red (urgent), amber (priority) and green (routine) follow up with suggestions of how often people should be seen. We also offer recommendation on how we can identify those at highest risk and try and minimise the long- term impact of COVID on diabetes careDuring the COVID pandemic we have seen things happen in days that previously took years. The restart of diabetes services has triggered a more widespread use of virtual consultations and data management systems, but also offers an opportunity for more joined-up and cohesive working between primary and specialist care. While we do our best to keep our patients and colleagues safe, this pandemic is already proving to be a catalyst for change, accelerating the appropriate use of technology in diabetes care and implementing innovative solutions. To achieve this aspiration, further work – currently led by the Association of British Clinical Diabetologists in collaboration with Diabetes UK and the Primary Care Diabetes Society – to make recommendations on future proofing diabetes care in UK is in progress.



Blood ◽  
2001 ◽  
Vol 98 (6) ◽  
pp. 1727-1731 ◽  
Author(s):  
Janna M. Journeycake ◽  
Charles T. Quinn ◽  
Kim L. Miller ◽  
Joy L. Zajac ◽  
George R. Buchanan

Abstract Central venous catheters (CVCs) are a common adjunct to hemophilia therapy, but the risk of CVC-related deep venous thrombosis (DVT) in hemophiliacs is not well defined. In a previous study, 13 patients with CVCs had no radiographic evidence of DVT. However, recent abstracts and case studies demonstrate that DVT does occur. Therefore, this study sought to determine the frequency of DVT in children with hemophilia and long-term CVCs and to correlate venographic findings with clinical features. All hemophilia patients with tunneled subclavian CVCs in place for 12 months or more were candidates for evaluation. Patients were examined for physical signs of DVT and questioned about catheter dysfunction. Contrast venograms were obtained to identify DVT. Fifteen boys with severe hemophilia were evaluated, including 9 from the initially studied group of 13. Eight patients had evidence of DVT, 5 of whom previously had normal venograms. Five of 15 patients had clinical problems related to the CVC, all of whom had DVT. Four of 15 patients had suggestive physical signs; 3 had DVT. The mean duration of catheter placement for all patients was 57.5 months (range, 12-102 months). For patients with DVT, the mean duration was 66.6 ± 7.5 months, compared to 49.5 ± 7.2 months for patients without DVT (P = .06). No patient whose CVC was in place fewer than 48 months had an abnormal venogram. Many hemophilia patients with CVCs develop DVT of the upper venous system, and the risk increases with duration of catheter placement.



Sign in / Sign up

Export Citation Format

Share Document